Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
56
Participants
Timeline
Start Date
February 29, 2016
Primary Completion Date
April 30, 2016
Study Completion Date
May 31, 2016
Conditions
Healthy
Interventions
DRUG
Leucostim®
DRUG
Neupogen®
Trial Locations (1)
03722
Severance Hospital, Yonsei University College of Medicine, Seoul
All Listed Sponsors
lead
Dong-A ST Co., Ltd.
INDUSTRY
NCT02725086 - Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter